Ether derivatives

Details Ether derivatives Ether derivatives

2005-03-17

2008-10-07

Shiao, Rei-tsang (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S255000

Reexamination Certificate

active

07432291

ABSTRACT:
The present invention provides the compounds of formula (I)their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.

REFERENCES:
patent: 7163953 (2007-01-01), Bossenmaier et al.
patent: 7235574 (2007-06-01), Bossenmaier et al.
patent: 1270571 (2003-01-01), None
patent: WO 98/03505 (1998-01-01), None
patent: WO 01/77107 (2001-10-01), None
patent: WO 03/031442 (2003-04-01), None
patent: WO 03/059907 (2003-07-01), None
Copending U.S. Appl. No. 11/073,065.
Wilks et al., Progress in Growth Factor Research, 2, pp. 97-111 (1990).
Chan et a., Cur. Opin. in Immunol., 8, pp. 394-401 (1995).
Yarden et al., Ann. Rev. Biochem., 57, pp. 443-478 (1988).
Wright et al., Br. J. Cancer, 65, pp. 118-121 (1992).
Baselga et al., Oncology, 63 (Suppl. 1), pp. 6-16 (2002).
Ranson et al., Oncology, 63 (Suppl. 1), pp. 17-24 (2002).
Bastin et al., Organic Proc. Res. Dev., 4, pp. 427-435 (2000).

Affiliated with

Also associated with

Rating

Ether derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ether derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ether derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3998932